A3833 (2025-26 session)

NY State bill

Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.

Title
Relates to capping cost sharing for antiviral COVID-19 therapeutics
Type
New York State Assembly bill
Session
2025-26 session
Status
In Assembly Committee
Latest action date
2026-01-07
In committee
Insurance
Introduced
2025-01-30
Law section
Insurance Law

Sponsors

Heard in committee

Sources